1. Home
  2. FRES vs WLGS Comparison

FRES vs WLGS Comparison

Compare FRES & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • WLGS
  • Stock Information
  • Founded
  • FRES 2010
  • WLGS 1981
  • Country
  • FRES British Virgin Islands
  • WLGS Hong Kong
  • Employees
  • FRES N/A
  • WLGS N/A
  • Industry
  • FRES Medical Specialities
  • WLGS Engineering & Construction
  • Sector
  • FRES Health Care
  • WLGS Consumer Discretionary
  • Exchange
  • FRES Nasdaq
  • WLGS Nasdaq
  • Market Cap
  • FRES 70.9M
  • WLGS 8.5M
  • IPO Year
  • FRES 2020
  • WLGS 2023
  • Fundamental
  • Price
  • FRES $2.96
  • WLGS $0.56
  • Analyst Decision
  • FRES
  • WLGS
  • Analyst Count
  • FRES 0
  • WLGS 0
  • Target Price
  • FRES N/A
  • WLGS N/A
  • AVG Volume (30 Days)
  • FRES 9.9K
  • WLGS 125.5K
  • Earning Date
  • FRES 07-23-2024
  • WLGS 08-02-2024
  • Dividend Yield
  • FRES N/A
  • WLGS N/A
  • EPS Growth
  • FRES N/A
  • WLGS N/A
  • EPS
  • FRES N/A
  • WLGS N/A
  • Revenue
  • FRES $2,345,304.00
  • WLGS $6,825,879.00
  • Revenue This Year
  • FRES N/A
  • WLGS N/A
  • Revenue Next Year
  • FRES N/A
  • WLGS N/A
  • P/E Ratio
  • FRES N/A
  • WLGS N/A
  • Revenue Growth
  • FRES N/A
  • WLGS 65.07
  • 52 Week Low
  • FRES $2.50
  • WLGS $0.40
  • 52 Week High
  • FRES $41.80
  • WLGS $1.46
  • Technical
  • Relative Strength Index (RSI)
  • FRES 40.27
  • WLGS 46.70
  • Support Level
  • FRES $2.81
  • WLGS $0.52
  • Resistance Level
  • FRES $3.70
  • WLGS $0.60
  • Average True Range (ATR)
  • FRES 0.40
  • WLGS 0.05
  • MACD
  • FRES 0.00
  • WLGS -0.01
  • Stochastic Oscillator
  • FRES 35.94
  • WLGS 13.33

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.

Share on Social Networks: